ProMIS Neurosciences (NASDAQ:PMN) Now Covered by Maxim Group
Investment analysts at Maxim Group began coverage on shares of ProMIS Neurosciences (NASDAQ:PMN – Get Free Report) in a research report issued to clients and investors on Monday, Marketbeat reports. The brokerage set a “buy” rating and a $3.00 price target on the stock. Maxim Group’s price target would indicate a potential upside of 476.92% […]
Investment analysts at Maxim Group began coverage on shares of ProMIS Neurosciences (NASDAQ:PMN – Get Free Report) in a research report issued to clients and investors on Monday, Marketbeat reports. The brokerage set a “buy” rating and a $3.00 price target on the stock. Maxim Group’s price target would indicate a potential upside of 476.92% […]
